Observation: In my RSL3-induced ferroptosis mouse model, no significant reduction in GPX4 protein levels was observed under certain treatment conditions.

Experimental Details:

  • RSL3 Administration: Vehicle: 10% DMSO + 90% corn oil (freshly prepared before each injection). Dosage & Schedule: Chronic treatment: Daily intraperitoneal (i.p.) injection for 3 or 6 consecutive days. Acute treatment: A single i.p. injection (30 mg/kg) at model induction, followed by sacrifice 24 hours later.

Notable Finding: Only the acute treatment (single high-dose RSL3, 24-hour endpoint) resulted in a modest decrease in GPX4 expression, whereas prolonged administration (3–6 days) did not significantly alter GPX4 levels.

Question: What could explain the absence of GPX4 suppression in the chronic RSL3 treatment group despite its established role in ferroptosis induction?

More Chloe Sun's questions See All
Similar questions and discussions